13D/13G Filings - Farallon Capital Partners L.P.

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, 2, 3, 4, Next
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-11-14
8:21 pm
Purchase
2024-11-0813GPerspective Therapeutics, Inc.
CATX
Farallon Capital Partners L.P.5,064,227
7.300%
5,064,227increase
(New Position)
Filing
History
2024-11-08
5:15 pm
Purchase
2024-09-3013GLongboard Pharmaceuticals, Inc.
LBPH
Farallon Capital Partners L.P.3,456,063
9.990%
1,250,073increase
(+56.67%)
Filing
History
2024-11-08
2:57 pm
Sale
2024-09-3013GAramark
ARMK
Farallon Capital Partners L.P.11,636,937
4.400%
-5,262,317decrease
(-31.14%)
Filing
History
2024-11-08
2:40 pm
Purchase
2024-09-3013GAgios Pharmaceuticals, Inc.
AGIO
Farallon Capital Partners L.P.5,660,866
9.900%
1,493,264increase
(+35.83%)
Filing
History
2024-11-08
11:54 am
Purchase
2024-09-3013GElevation Oncology, Inc.
ELEV
Farallon Capital Partners L.P.3,527,482
6.000%
427,482increase
(+13.79%)
Filing
History
2024-11-07
09:56 am
Purchase
2024-09-3013GBeam Therapeutics Inc.
BEAM
Farallon Capital Partners L.P.8,208,123
9.900%
4,102,370increase
(+99.92%)
Filing
History
2024-11-06
6:32 pm
Purchase
2024-09-3013GSavara Inc.
SVRA
Farallon Capital Partners L.P.17,762,533
9.990%
3,435,622increase
(+23.98%)
Filing
History
2024-11-06
5:06 pm
Sale
2024-09-3013GSwiftmerge Acquisition Corp.
IVCP
Farallon Capital Partners L.P.471,366
9.900%
-53,634decrease
(-10.22%)
Filing
History
2024-10-16
4:35 pm
Purchase
2024-10-0913DSquarespace, Inc.
SQSP
Farallon Capital Partners L.P.5,600,000
6.100%
5,600,000increase
(New Position)
Filing
History
2024-05-17
4:58 pm
Purchase
2024-05-0913GNanoString Technologies, Inc.
NSTGQ
Farallon Capital Partners L.P.4,391,941
9.100%
4,391,941increase
(New Position)
Filing
History
2024-05-08
4:11 pm
Purchase
2024-05-0613DExelixis, Inc.
EXEL
Farallon Capital Partners L.P.26,769,500
9.200%
909,500increase
(+3.52%)
Filing
History
2024-02-14
09:33 am
Purchase
2023-12-3113GForte Biosciences, Inc.
FBRX
Farallon Capital Partners L.P.151,740
9.900%
234increase
(+0.15%)
Filing
History
2024-02-12
5:11 pm
Sale
2023-12-3113GRevolution Medicines, Inc.
RVMD
Farallon Capital Partners L.P.6,750,204
4.100%
-12,276decrease
(-0.18%)
Filing
History
2024-02-12
3:38 pm
Sale
2023-12-3113GBeam Therapeutics Inc.
BEAM
Farallon Capital Partners L.P.4,105,753
5.000%
-7,716decrease
(-0.19%)
Filing
History
2024-02-08
11:39 am
Purchase
2023-12-3113GAgios Pharmaceuticals, Inc.
AGIO
Farallon Capital Partners L.P.4,167,602
7.500%
206,000increase
(+5.20%)
Filing
History
2024-02-06
10:16 am
Purchase
2023-12-3113GAramark
ARMK
Farallon Capital Partners L.P.16,899,254
6.400%
1,518,185increase
(+9.87%)
Filing
History
2024-02-05
5:28 pm
Unchanged
2024-02-0113DCazoo Group Ltd
CZOOF
Farallon Capital Partners L.P.7,142
14.600%
0
(Unchanged)
Filing
History
2024-02-05
11:22 am
Sale
2023-12-3113GSwiftmerge Acquisition Corp.
IVCP
Farallon Capital Partners L.P.525,000
9.000%
-1,680,000decrease
(-76.19%)
Filing
History
2024-02-02
09:19 am
Purchase
2023-12-3113GProtagonist Therapeutics, Inc.
PTGX
Farallon Capital Partners L.P.5,765,109
9.990%
710,007increase
(+14.05%)
Filing
History
2024-02-01
3:50 pm
Purchase
2023-12-3113GSavara Inc.
SVRA
Farallon Capital Partners L.P.14,326,911
9.990%
14,326,911increase
(New Position)
Filing
History
Goto 0, 1, 2, 3, 4, Next